Feedback about Omixon Target HLA

Our CTO, Tim Hague, just informed us about the incredibly positive feedback he has recently received about our Omixon Target HLA software solution. We also restructured its page in order to make the core messages even more clear.

Omixon Target HLA offers the highest possible HLA typing precision.  There is no need to be an expert in NGS analysis and to spend hours editing the sequence.

Feedback about Omixon Target HLA

Some of the feedback he got during a demonstration of Omixon Target HLA Typing:

“It is a quantum leap over anything we have seen.”

 

About the approval process: “This is a nice feature, especially in a clinical setting.”

 

”You should see my face (client said to Tim, who was on the phone). I am smiling. I am like a kid at Christmas.”

Presenting at the 27th EFI European Immunogenetics and Histocompatibility Conference

We are proud to announce that the submissions for an oral and two poster presentations of our CEO, Attila Bérces, were accepted for the upcoming 27th annual EFI European Immunogenetics and Histocompatibility Conference in Maastricht, The Netherlands.

After several conferences this year, there is a new chance for showing what we do with Omixon Target and how it can be useful in cancer research, HLA typing and many other fields of medicine and science.

We plan to publish updates during the conference as well!

Presenting at the 27th EFI European Immunogenetics and Histocompatibility Conference